Pharmabiz

Trialbee appoints Michael Meerovich as chief financial officer to accelerate global growth strategy

Trialbee appoints Michael Meerovich as chief financial officer to accelerate global growth strategy: Malmo, Sweden Saturday, July 25, 2026, 18:00 Hrs [IST] Trialbee, the global le ...
Pharmabiz

Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx in epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx in epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: Santa Clara, California Saturday, July 25, 2026, 17 ...
Pharmabiz

Lundbeck receives US FDA fast track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy

Lundbeck receives US FDA fast track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy: Valby, Denmark Saturday, July 25, 2026, 16:00 Hrs [IST ...
Pharmabiz

EMA committee recommends approval of AstraZeneca & Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment for patients with HER2-positive metastatic breast cancer

EMA committee recommends approval of AstraZeneca & Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment for patients with HER2-positive metastatic breast cancer: Camb ...
Pharmabiz

Fortis Hospitals launches 'Har Ghar Hero' initiative to make Mumbai CPR-ready

Fortis Hospitals launches 'Har Ghar Hero' initiative to make Mumbai CPR-ready: Our Bureau, Mumbai Saturday, July 25, 2026, 14:20 Hrs [IST] Fortis Hospitals Mumbai announced the la ...